Royal Bank of Canada Reiterates Outperform Rating for Smith & Nephew (LON:SN)

Royal Bank of Canada restated their outperform rating on shares of Smith & Nephew (LON:SN) in a report issued on Tuesday, Marketbeat reports. The firm currently has a GBX 1,500 ($18.84) price target on the stock.

SN has been the topic of a number of other research reports. Jefferies Financial Group reissued a buy rating and set a GBX 1,250 ($15.70) price objective on shares of Smith & Nephew in a research note on Friday, May 3rd. Barclays reissued an equal weight rating and set a GBX 1,150 ($14.45) price objective on shares of Smith & Nephew in a research note on Friday, February 9th. Berenberg Bank reissued a buy rating and set a GBX 1,450 ($18.22) price objective on shares of Smith & Nephew in a research note on Thursday, May 2nd. Finally, JPMorgan Chase & Co. lifted their target price on Smith & Nephew from GBX 1,300 ($16.33) to GBX 1,381 ($17.35) and gave the company an overweight rating in a research report on Thursday, May 2nd. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of Moderate Buy and a consensus price target of GBX 1,346.20 ($16.91).

Smith & Nephew Stock Performance

LON SN opened at GBX 997.80 ($12.54) on Tuesday. The company has a market cap of £8.72 billion, a PE ratio of 4,153.33, a price-to-earnings-growth ratio of 0.46 and a beta of 0.51. The stock’s 50 day simple moving average is GBX 1,013.03 and its 200-day simple moving average is GBX 1,036.71. Smith & Nephew has a 1-year low of GBX 887 ($11.14) and a 1-year high of GBX 1,316.75 ($16.54). The company has a debt-to-equity ratio of 59.11, a current ratio of 1.77 and a quick ratio of 0.84.

Smith & Nephew Increases Dividend

The firm also recently announced a dividend, which will be paid on Wednesday, May 22nd. Shareholders of record on Thursday, March 28th will be given a $0.23 dividend. The ex-dividend date of this dividend is Thursday, March 28th. This represents a yield of 1.62%. This is an increase from Smith & Nephew’s previous dividend of $0.14. Smith & Nephew’s payout ratio is currently 12,500.00%.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.